CODX
Co-Diagnostics, Inc.Company with tickers: CODX
CIK
1692415
CUSIP
189763204
Shares Outstanding
3,657,380
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $50,277 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | $21,590 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | $28,687 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $8,580,643 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $4,870,019 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-8,551,956 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-7,533,271 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-7.05 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-7.05 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |